failure to respond or late response
on 21 Nov 2020
Last Applicant/ Owned by
One Amgen Center Drive
Thousand Oaks
CA
913201799
Serial Number
88723059 filed on 11th Dec 2019
Registration Number
N/A
Correspondent Address
Elsa D. Lemoine
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations, namely, pharmaceutical preparations, substances and biosimilars used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations, substances and biosimilars for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskelRead More
Pharmaceutical preparations, namely, pharmaceutical preparations, substances and biosimilars used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations, substances and biosimilars for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations, substances and biosimilars used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, Pyoderma Gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma
No 88723059
No Service/Collective Mark
No TM-1399-US-2
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 23rd Nov 2020 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 21st Nov 2020 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 10th May 2020 | NON-FINAL ACTION WRITTEN |
| 10th May 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 10th May 2020 | NON-FINAL ACTION E-MAILED |
| 09th May 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 08th May 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 08th May 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 27th Dec 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 27th Dec 2019 | NON-FINAL ACTION WRITTEN |
